4CNM
Crystal structure of human 5T4 (Wnt-activated inhibitory factor 1, Trophoblast glycoprotein)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I02 |
Synchrotron site | Diamond |
Beamline | I02 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2013-04-26 |
Detector | DECTRIS PILATUS 6M |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 49.310, 67.310, 96.380 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 43.940 - 1.750 |
R-factor | 0.18365 |
Rwork | 0.182 |
R-free | 0.22153 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3zyj |
RMSD bond length | 0.016 |
RMSD bond angle | 1.833 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.7.0032) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 49.310 | 1.800 |
High resolution limit [Å] | 1.750 | 1.750 |
Rmerge | 0.070 | 0.810 |
Number of reflections | 33062 | |
<I/σ(I)> | 17.9 | 3.1 |
Completeness [%] | 99.8 | 99.2 |
Redundancy | 9.6 | 9.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | THE CRYSTALLIZATION DROP CONTAINED 100 NL OF CONCENTRATED 5T4 (5.5 MG/ML), 100 NL OF 25% W/V POLYETHYLENE GLYCOL (PEG) 3350, 0.1 M CITRATE PH 3.5, AND 0.5 NL OF 0.1 M NAOH |